Simple Summary: Nodular sebaceous gland hyperplasia refers to wartlike, hairless nodules that are common in middle-aged to old dogs. If it disturbs the dog, it is usually removed by surgical excision. As anesthesia is associated with risk, which is increased in older patients, an alternative to surgery is desirable. A solution containing nitric acid, zinc, copper, and organic acids (Verrutop®, ISDIN, Barcelona, Spain) is used to treat difficult warts in humans. In this study, it was applied to nodules that grossly appeared as sebaceous gland hyperplasia. The treatment was carried out on awake dogs. Eleven dogs with a total of 29 sebaceous gland nodules were included in this study. Eighteen of the nodules were treated, and 11 were not treated as a comparison. Four weeks after one treatment, 17/18 of the treated nodules were gone. There was a statistically significant difference in the percentual volume change from day 0 to day 28 between the treated and untreated sebaceous gland nodules. There were no serious side effects. Both the owners of the dogs and the veterinarians were satisfied with this treatment. Verrutop® is an efficient and easy way to remove sebaceous gland hyperplasia in dogs, with minimal side effects. Nodular sebaceous gland hyperplasia in the often middle-aged to old dog is a common, benign proliferation that results in exophytic, pink to yellow, alopecic, and often multilobulated nodules. Removal is usually carried out by surgical excision. As many old dogs have comorbidities that increase the risk of anesthesia, a topical treatment is warranted. We hypothesized that the application of a solution containing nitric acid, zinc, copper, and organic acids (Verrutop®), would be a safe and efficient way to treat these nodules. Eleven dogs with a total of 29 nodules, grossly compatible with nodular sebaceous gland hyperplasia, were included in the study. Eighteen of the nodules were treated; 11 were left untreated. No anesthesia or sedation was needed. Four weeks after one application, 17/18 treated nodules had decreased by 100% in volume. There was a statistically significant difference in percentual volume change between the treated and untreated nodules from day 0 to day 28 (p < 0.0001). No serious side effects were noted. Sebaceous hyperplasia cannot always be distinguished grossly from sebaceous tumors. Cytological evaluation can be helpful, and in cases of deviant macroscopic features, local recurrence, or more aggressive behavior, the appropriate intervention would be to biopsy or excise the nodule for histopathology. Topical application of Verrutop® is an easy, low-cost, and efficient way to remove canine sebaceous gland hyperplasia with minimal side effects in cases where surgery and anesthesia are not desired. [ABSTRACT FROM AUTHOR]